Head-to-head · free
IREN Limited vs Lam Research
IREN vs LRCX — return on capital, cash generation, margins and balance sheet side by side.
IREN
3 / 7
measures where IREN leads
LRCX
4 / 7
measures where LRCX leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | IREN · FY2026 | LRCX · FY2026 |
|---|---|---|
| Revenue | $707.0M | $23.2B |
| Net income | (702.6M) | $7.3B |
| Revenue growth (yearly, multi-year) | 41.1% | 7.8% |
| Free cash flow | (897.6M) | — |
| Free cash flow margin | -127.0% | — |
| Net cash / (debt) | — | — |
| ROIC | — | 46.0% |
| Return on equity | -23.4% | 65.1% |
| Gross margin | 62.3% | 50.5% |
| Operating margin | -53.6% | 35.3% |
| Net debt / EBITDA | -2.70x | -0.21x |
Figures are as reported by each company; latest fiscal year shown.
Where IREN Limited's cash went (FY2026)
- Capital spending
- $3.0B
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Where Lam Research's cash went (FY2026)
- Capital spending
- —
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free